The Measures To Control Drug Cost In The Medicaid And Experience For Reference To China

BackgroundIn recent years, the total health expenditure in China is rapidly growing, including the expansion of drugs expenses is one of the main reasons to promote the growth of total health expenditures. Since the implementation of the new health care reform in2009,the drug costs growth rate still cannot be ignored, and the proportion of drug costs accounted for the total cost of health care is still a high level. In our general hospitals, the proportion of pharmaceutical costs accounted for health care costs is still about50%, this phenomenon is more serious in the new rural cooperative medical system. The new rural cooperative medical system is farmers’medical mutual helping systems organized, guided and supported by the government, farmers voluntary participation, individual collective and government multilateral financing and serious illness and Manpower. It is the important content of China’s rural social security system.In the new rural cooperative medical system, the proportion of drug costs accounted for NEMS is much higher than the proportion of the total cost of drugs accounted for total health costs in general hospitals. High pharmaceutical expenditures bring heavy burden to China’s rural residents, therefore control drug costs growth in NEMS is important tool to control the total funding, reducing the burden on the residents, solve the difficult medical services and expensive medical cost. The American medical aid system is the medical security system that dominated and financed by the government, aim to provide free pharmacy benefits for low-income people, this system has been implemented for a long time. In terms of control Medicaid drug costs, it takes a variety of different measures for controlling drugs costs, such as co-payment system and pre-licensing system and preferred list of drugs and so on, these measures have obtained the tangible effect.PurposeIn2009Nation launched a new round of reform of the health care system, our country has introduced a series of measures to control drug costs, for example, the implementation of "zero profit drug" system at the grassroots level, the establishment of essential medicines list, the implementation of drug procurement tender, but drug costs management has just started, drug costs are still high, the effect of the measures is not obvious, even appeared some phenomenon of increasing rather than reducing the cost of drugs. At present, China still has some gaps in the efforts to control drug costs, medical expenses still give a huge burden on people, the phenomenon of "being into poverty by illness " still occurs, so this paper studies and summarizes major policies and measures of controlling medical assistance system drug expenses organized by the state government and provides corresponding advice to control the total cost of the new rural cooperative, reduce the burden on the people to see a doctor, maintain social harmony and stability.Research MethodsUsing the Public Management and Drug Economics as a theoretical basis, combining the Government Financial Management and Health Management as well as comparative analysis, qualitative and quantitative analysis. And also referring to a large number of documents, extracting relevant information and data analysis.Source:CNKI academic literature pool, a database of ten thousand, the United States government website, American medical aid studies and other related websites, etc., the Chinese department of health and China health statistics yearbook and so on.Research content1, understand the basic situation of American medical assistance system 2, introduce the U.S. Medicaid drug cost control measures in detail, respectively from the total payment system, the preferred list of drugs, pre-licensing system, limiting the number of prescriptions, and popularizing generic drugs.3, learn about the drug expenditures of Medicaid, and the measuresto drug cost control in Medicaid in detail, respectively from the overall price control,co-payment, preferred drug lists,prior authourization, limit the number of prescriptions, the promotion of generic drugs measures in several aspects, such as research, and the measures of effectiveness and efficiency of medical rescue system to study the influence of drug cost control.3, compared with the Chinese NEMS, provide experience for controlling drug costs in China’s new rural cooperative medical systemResultThrough the study we found that the drug cost control measures in theMedicaid of the states have played a good and obvious effect in controlling drug costs.First The American Medicaid price control measures guarantee the accessibility of drug, promote the realization of the drug benefits. Second, through the study we found that states the specific drug costs rather than being a single implementation of control measures,ie is a variety of control measures basing their own economic condition and population geography.It has a different list of priority medicines, making different reimbursement ratio, different proportion of total pay system, in the process of promoting generics adopted different methods respectively, adjust measures to local conditions. After the implementation of Limit the number of prescription, each prescription in the number of drugs and the quantities of prescriptions each month are under control. Taking the measure of Priority Authorization, drug market shift to the low cost market,.Priority Authorization directly achieve a certain degree of cost savings.The PA limit the implemention of non-preferrit list drug, in the five states of the investigation, the rising cost of drugs through the measure are under control. Indirect control cost measures such as the implementation of the co-payment, greatly reduces the utilization of drugs. The measure of encouraging generics drug makes a percentage of generic drugs in the prescription since2006is higher than the proportion of patent medicine.